Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
121.41
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
120.97 (100)
Ask (Size)
121.41 (1,600)
Prev. Close
121.41
Today's Range
121.41 - 121.41
52wk Range
73.31 - 123.33
Shares Outstanding
2,531,374,696
Dividend Yield
2.80%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards
Today 11:43 EST
As the oncology community prepares to descend upon San Francisco for the 2026 ASCO Genitourinary (GU) Cancers Symposium from February 26–28, investors and clinicians alike are bracing for data that...
Via
MarketMinute
Topics
Intellectual Property
8 Cheap Stocks to Buy in 2026
↗
Today 9:45 EST
All 8 stocks with big upside
Via
The Motley Fool
Performance
YTD
+14.1%
+14.1%
1 Month
+11.6%
+11.6%
3 Month
+30.7%
+30.7%
6 Month
+44.2%
+44.2%
1 Year
+45.8%
+45.8%
More News
Read More
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
↗
February 14, 2026
Via
The Motley Fool
Topics
Stocks
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
↗
February 14, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
Moderna Shares Surge as Aggressive Cost-Cutting and Post-Pandemic Pivot Take Hold in Q4 Results
February 13, 2026
Via
MarketMinute
Topics
Earnings
Did Eli Lilly Just Make a Deal for Its Next Blockbuster Drug?
↗
February 13, 2026
Via
The Motley Fool
Dow Jones 267-Point Slide: Blue-Chip Leaders and the AI Reality Check
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
3 Mega-Cap Stocks for Long-Term Investors
February 12, 2026
Via
StockStory
Topics
Supply Chain
The Great Rebound: US M&A Market Ignites as Megadeals Surge 111% in AI-Driven Supercycle
February 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Energy
The Great Rotation: Healthcare Emerges as the S&P 500’s New Crown Jewel in 2026
February 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Zoetis Inc. (ZTS): Navigating Innovation and Safety in a Mature Animal Health Market
February 12, 2026
Via
Finterra
Topics
Artificial Intelligence
Earnings
Economy
The Bioelectronic Frontier: A Deep-Dive into NovoCure’s Multi-Indication Transformation
February 12, 2026
Via
Finterra
Topics
Initial Public Offering
Intellectual Property
Merck Advances Treatment of Bladder and Kidney Cancers with New Data at 2026 ASCO GU Cancers Symposium
February 12, 2026
From
Merck & Co., Inc.
Via
Business Wire
KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Plus Paclitaxel ± Bevacizumab, Approved for Certain Adults with PD-L1+ (CPS ≥1) Platinum-Resistant Ovarian Carcinoma as Second or Third Line Treatment
February 11, 2026
From
Merck & Co., Inc.
Via
Business Wire
AstraZeneca Signals a New Era in Obesity Care: Earnings Report Teases Oral GLP-1 Powerhouse
February 10, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
Gilead’s Second Act: A 2026 Deep Dive into the Transition from Virology to Oncology Powerhouse
February 10, 2026
Via
Finterra
Topics
Economy
Intellectual Property
5 Revealing Analyst Questions From Merck’s Q4 Earnings Call
February 10, 2026
Via
StockStory
Topics
Earnings
Intellectual Property
Stock Market Today, Feb. 9: Oracle Climbs on AI Optimism Despite Software Sector Weakness
↗
February 09, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Stocks
3 Top Dow Jones Dividend Stocks to Buy for Passive Income in 2026
↗
February 08, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
Stocks
AstraZeneca’s Strategic Takeover of Modella AI Signals the Rise of Agentic Oncology
February 06, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Fiscal Brinkmanship: Data Blackout and the DHS Cliff Loom Over Markets After Narrow Funding Deal
February 06, 2026
Via
MarketMinute
Topics
Economy
Government
Immigration
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
February 06, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
The Phoenix of Big Pharma: A 2026 Deep-Dive into AstraZeneca’s Global Dominance
February 06, 2026
Via
Finterra
Topics
Economy
Government
Intellectual Property
Trump Administration To Launch TrumpRx Platform For Discounted Drugs Later On Thursday: Reports
↗
February 05, 2026
Via
Stocktwits
Topics
Economy
Government
World Trade
USDA Unveils $100 Million 'Grand Challenge' to Thwart Flesh-Eating Screwworm as Threat Reaches U.S. Border
February 05, 2026
Via
MarketMinute
Topics
Death
Economy
Frequently Asked Questions
Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 121.41
When was Merck & Co last traded?
The last trade of Merck & Co was at 02/13/26 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 307.33B
How many shares of Merck & Co are outstanding?
Merck & Co has 307B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.